INS and diabetes mellitus: We also found that serum TAGE levels were significantly reduced by a DPP-4 inhibitor [110], sulfonyl urea [111], and insulin [112], and these decreases were associated with reductions in the levels of biomarkers of organ damage in DM and CKD patients.